Abuse-resistant oxycodone primed for clinical trials
IntelliPharmaCeutics is ready to move into full-scale clinical trials with a once-daily oral formulation of oxycodone based on the company's ReXista abuse- and alcohol-resistant technology.
Archives for March 30, 2008
DSM now offering commercial cytotoxic services
DSM Pharmaceuticals now has its new commercial scale cytotoxic contract manufacturing facility up and running, and is only the second company in the US to offer such a service on this scale.
Thermo unveils FT-IR spectrometer
Thermo Fisher has launched a new spectrometer that incorporates FT-IR technology for improved clarity and detail, aimed at pharmaceutical process scientists and other chemical disciplines.
California gives industry a two-year reprieve on ePedigree
Pharmaceutical manufacturers, distributors and retailers alike have welcomed a unanimous vote by the California State Board of Pharmacy to delay for another two years the implementation of electronic pedigree requirements for tracking drugs from the...
SGS launches supply chain safety services
SGS has officially launched a new auditing service designed to alleviate the quality, regulatory and safety issues in pharmaceutical supply chains, which are increasingly extending across the globe.
Credit crunch sinks MonoSol IPO
A planned $60-$70m (€38-€44m) initial public offering (IPO) by US-based drug delivery specialist MonoSol Rx has fallen foul of the credit crunch and fears about a slowing US economy.
Wyeth cuts 1200 sales reps
1200 sales representatives are the latest casualties of Wyeth's recently announced cost cutting drive, which strives to eliminate 10 per cent of the work force - 5,000 jobs - over the next three years.